The quality and utility of pharmacogenomic tests should increase over time. Psychiatrists in training will need to know how to consider whether these products are a useful guide to the management of their patients. They will need to respond to patients who may request such genetic testing or bring results of pharmacogenetic tests to their appointments. The NNCI recently released an educational module that highlights a commentary on this topic.53
